-+ 0.00%
-+ 0.00%
-+ 0.00%

*Cytokinetics: Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in 4Q >CYTK

Dow Jones·08/06/2026 20:00:00

Please log in to view news